Company profile
Rapidemic company profile
Rapidemic develops a molecular point-of-care test for the diagnosis of sexually transmitted infections. Their proprietary technology increases the sensitivity and specificity of the reaction while keeping manipulations to a minimum. Its technology enables low-temperature diagnostics while safeguarding accuracy and reducing false positives.
Business identity
- Website
- https://rapidemic.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2020-01-01, Year
Headquarters
- Headquarters
- Leiden, South Holland, The Netherlands
- Postal code
- 2312
- Country code
- NL
- Continent
- Europe